Dr Abdulkaher Al-jonaid, PHARM D | |
2525 Harris St, Eureka, CA 95503-4805 | |
(707) 444-0521 | |
(707) 444-0526 |
Full Name | Dr Abdulkaher Al-jonaid |
---|---|
Gender | Male |
Speciality | Pharmacist |
Location | 2525 Harris St, Eureka, California |
Accepts Medicare Assignments | Does not participate in Medicare Program. He may not accept medicare assignment. |
Identifier | Type | State | Issuer |
---|---|---|---|
1215219985 | NPI | - | NPPES |
Taxonomy | Type | License (State) | Status |
---|---|---|---|
183500000X | Pharmacist | 62069 (California) | Primary |
Mailing Address | Practice Location Address |
---|---|
Dr Abdulkaher Al-jonaid, PHARM D 2525 Harris St, Eureka, CA 95503-4805 Ph: (707) 444-0521 | Dr Abdulkaher Al-jonaid, PHARM D 2525 Harris St, Eureka, CA 95503-4805 Ph: (707) 444-0521 |
News Archive
Minimally invasive techniques have become standard for many procedures, from the removal of the gallbladder to angioplasty, but the approach is now only beginning to be available to patients with spinal conditions. The surgical team at NewYork-Presbyterian Hospital/Columbia University Medical Center's Spine Center aims to bring the benefits of minimally invasive surgery for patients with intractable back pain, stenosis, spinal deformity, even spinal cancer.
Today the Proceedings of the National Academy of Sciences publishes a paper by Temple University researchers that details one of the functions of the c-myb gene (which leukemia cells depend on for proliferation), the formation of white blood cells.
Antibe Therapeutics Inc. is proud to announce that Dr. John Wallace, the Corporation's Founder and Chief Science Officer, was awarded the Heymans Foundation Memorial Medal in Ghent, Belgium, today.
Data to be presented at the 51st Annual Meeting of the American Society of Clinical Oncology suggest that the investigational immunotherapy MPDL3280A may double the likelihood of overall survival in the study period (HR=0.47), compared with docetaxel chemotherapy, in individuals with non-small cell lung cancer (NSCLC) who expressed the highest levels of PD-L1 (a receptor present on cancer cells).
Researchers from the Cognition and Brain Plasticity research group of the Bellvitge Biomedical Research Institute and the University of Barcelona, in collaboration with several hospitals, have discovered that an intellectually active lifestyle confers protection against neurodegeneration in people with Huntington's disease, delaying the onset of symptoms and loss of grey matter in the brain.
› Verified 2 days ago
Ashley Brooke Savio, PHARMD Pharmacist Medicare: Not Enrolled in Medicare Practice Location: 2700 Dolbeer St, Eureka, CA 95501 Phone: 707-445-8121 Fax: 707-269-3731 | |
Alexander L Nguyen, PHARMD Pharmacist Medicare: Not Enrolled in Medicare Practice Location: 1105 Myrtle Ave, Eureka, CA 95501 Phone: 707-443-5081 | |
Rebecca Sheets, PHARM. D. Pharmacist Medicare: Not Enrolled in Medicare Practice Location: 2280 Harrison Ave Ste B, Eureka, CA 95501 Phone: 707-443-9371 | |
Dr. Sean Pendley, PHARMD. Pharmacist Medicare: Not Enrolled in Medicare Practice Location: 2525 4th St, Eureka, CA 95501 Phone: 707-442-0549 | |
Dr. Michael D Hutchison, PHARM.D.,CDM Pharmacist Medicare: Not Enrolled in Medicare Practice Location: 714 F St, Eureka, CA 95501 Phone: 707-268-2448 Fax: 707-442-4023 | |
Dr. John Anthony Backus, PHARMD Pharmacist Medicare: Not Enrolled in Medicare Practice Location: 525 5th St, Eureka, CA 95501 Phone: 707-443-1614 | |
Kayla Quick, PHARMACIST Pharmacist Medicare: Not Enrolled in Medicare Practice Location: 2700 Dolbeer St, Eureka, CA 95501 Phone: 707-445-8121 |